Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 17 of 17

List	Outcome	Time frame	Description
Primary	Prevalence of Fragility Fractures in Adult Patients with DMD	Baseline	To determine the prevalence of extremity fractures in adult patients with Duchenne muscular dystrophy based on review of clinical records.
Secondary	Prevalence of Vertebral Fractures in Adult Patients with DMD	Baseline	To determine the prevalence of vertebral fractures in adult patients with Duchenne muscular dystrophy based on lateral thoracolumbar spine radiographs (T4-L4).
Secondary	Fracture Treatment Patterns	Baseline	To describe the treatments administered for fragility fractures in adult patients with Duchenne muscular dystrophy.
Secondary	Serum Biomarkers of Bone Metabolism and Bone-Muscle Crosstalk	Baseline	To measure serum analytes involved in bone metabolism and bone-muscle crosstalk in patients with DMD and compare their levels with those of healthy male controls.
Secondary	Genetic Modifiers Associated with Fracture Risk	Baseline	To identify genetic variants potentially associated with an increased risk of fractures in patients with DMD through DNA analysis and genome-wide association studies (GWAS).
Secondary	Bone Mineral Density of the Lumbar Spine (L1-L4)	Baseline	To assess bone mineral density at the lumbar spine (L1-L4) using dual-energy X-ray absorptiometry (DXA).
Secondary	Bone Mineral Density of Total Body Less Head (TBLH)	Baseline	To assess bone mineral density of total body less head (TBLH) using dual-energy X-ray absorptiometry (DXA).
Secondary	Peak Expiratory Flow (PEF)	Baseline	To assess respiratory function by measuring peak expiratory flow (PEF).
Secondary	Forced Vital Capacity (FVC)	Baseline	To assess respiratory function by measuring forced vital capacity (FVC).
Secondary	Respiratory Support Status	Baseline	To record respiratory support status at the study visit.
Secondary	Presence of Scoliosis	Baseline	To record the presence of scoliosis based on the orthopedic assessment.
Secondary	Presence of Contractures	Baseline	To record the presence of contractures based on the orthopedic assessment.
Secondary	Other Orthopedic Deformities	Baseline	To characterize other orthopedic deformities identified during the orthopedic assessment.
Secondary	History of Arthrodesis	Baseline	To record whether the patient has undergone an arthrodesis procedure, based on the clinical history and orthopedic assessment.
Secondary	Motor Function Assessed by NSAA	Baseline	To assess motor function using the North Star Ambulatory Assessment (NSAA).
Secondary	Upper-Limb Function Assessed by PUL	Baseline	To assess upper-limb motor function using the Performance of Upper Limb (PUL) scale.
Secondary	Walking Capacity Assessed by 6MWT	Baseline	To assess walking capacity using the Six-Minute Walk Test (6MWT).

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07890883/registered

API reference For AI assistants